About Us  |  Contact Us  |  Español
Woman And Infants
Leapfrog Group Top Hospital Designation
Woman And Infants

MaterniT21

MaterniT21 Plus:  DNA-Based Down syndrome test

Current Down syndrome tests are only screening tests that do not diagnose Down syndrome, but rather estimate the risk that the fetus may be affected. Although these screening tests have had a fairly significant false positive rate, pregnant women and their doctors have relied on them for years because they were all that was available. However, a new DNA-based screening test  has recently been developed.

High-risk women now have the option of undergoing a screening test that has a detection rate of greater than 99% for Down syndrome with a very low false positive rate. The MaterniT21 Plus test is a simple blood test that examines fetal DNA in maternal blood and can give accurate information to pregnant women about Down syndrome as well as two other common chromosomal abnormalities, trisomy 18 and trisomy 13. This test is currently only available to high-risk women.

Registration for Childbirth and parenting classes
Health Headlines
Xtoro Approved for Swimmer's EarView in a lightbox
Arriving Now at Gate 42: MeaslesView in a lightbox
Many Flu Infections Aren't Good Match for Vaccine: CDCView in a lightbox
Most States Not Ready to Handle Infectious Disease Outbreaks: ReportView in a lightbox
'Homing Signal' in Brain Helps Humans Navigate, Research ShowsView in a lightbox
Answers to your most pressing questions
Woman And Infants
© 2011 Site Index | Disclaimer | Legal Notices | Talks Your Health